Skip to main content
Shalby Limited logo

Shalby Limited — Investor Relations & Filings

Ticker · SHALBY ISIN · INE597J01018 LEI · 335800RVKD2F29DRCR78 BSE.NS Human health and social work activities
Open in API
Filings indexed 793 across all filing types
Latest filing 2020-06-15 Call Transcript
Country IN India
Listing BSE.NS SHALBY

About Shalby Limited

https://www.shalby.org

Shalby Limited is a multi-specialty organization recognized for its expertise in orthopedics and joint replacement surgery. The entity operates a network of facilities offering comprehensive medical services, including cardiology, oncology, neurology, and nephrology. It is distinguished by its high volume of orthopedic procedures and the implementation of the "Zero Technique" for knee replacements, designed to minimize surgical duration and accelerate patient recovery. In addition to clinical care, the organization maintains a presence in the orthopedic implant sector through its manufacturing division, which produces specialized implants and surgical instrumentation. The group focuses on providing tertiary and quaternary care utilizing advanced diagnostic and therapeutic infrastructure to serve a diverse patient base.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 85% confidence The document is an invitation to a conference call discussing the Q4FY20 results of Shalby Limited. It includes details such as date, time, dial-in numbers, and contact information for RSVP. There is no actual transcript or financial data presented, only an announcement of the call. Therefore, this document is best classified as a Call Transcript announcement or invitation, but since it does not contain the transcript itself, it is not a full Call Transcript (CT). However, given the options, the closest and most appropriate classification is Call Transcript (CT) as it relates to the conference call event.
2020-06-15 English
Investor Presentation
Regulatory Filings
2020-06-15 English
Outcome of Board Meeting
Annual Report Classification · 95% confidence The document is a detailed disclosure from the Board Meeting of Shalby Limited dated June 15, 2020. It includes the approval of audited financial results for the quarter and year ended March 31, 2020, along with the auditors' report and board's report. It also mentions dividend recommendations and appointments of auditors. The document contains actual financial data tables and detailed financial results, not just an announcement or a brief summary. The presence of audited financial results and the board's report indicates this is a comprehensive annual financial report. The document is not a short announcement or a certification letter but a full report with substantive financial data. Therefore, it fits the definition of an Annual Report (10-K equivalent).
2020-06-15 English
Dividend
Annual Report Classification · 95% confidence The document is a detailed disclosure from the Board Meeting of Shalby Limited dated June 15, 2020. It includes the approval of audited financial results for the quarter and year ended March 31, 2020, along with the auditors' report and board's report. It also mentions dividend recommendations and appointments of auditors. The document contains actual financial data tables and detailed financial results, not just an announcement or a brief summary. The presence of audited financial results and the board's report indicates this is a comprehensive annual financial report. Therefore, this document fits the definition of an Annual Report (10-K equivalent).
2020-06-15 English
Financial Result Updates
Regulatory Filings
2020-06-15 English
Board Meeting — Dividend
Regulatory Filings Classification · 95% confidence The document is a short notice from Shalby Limited addressed to stock exchanges regarding a forthcoming Board meeting scheduled for June 15, 2020. The purpose of the meeting is to consider and approve audited financial results for the quarter and year ended March 31, 2020, and to consider the recommendation of a final dividend for FY 2019-20. The document references Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements), which pertains to board meeting disclosures. The document does not contain any financial data or results itself, but rather informs about the agenda of the upcoming board meeting. The length is only 1589 characters, which is short and consistent with an announcement rather than a full report. According to the rules, such a document is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement about a board meeting and dividend consideration, not the actual dividend declaration or financial report.
2020-06-11 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.